c-RET Antibody

Contact us
NSJ Bioreagents
Product Code: NSJ-V8056
Product Group: Primary Antibodies
Supplier: NSJ Bioreagents
CodeSizePrice
NSJ-V8056-20UG20 ug£264.00
Quantity:
NSJ-V8056-100UG100 ug£534.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: Mouse IgG2b, kappa
Antibody Clonality: Monoclonal
Antibody Clone: RET/2662
Regulatory Status: RUO
Target Species: Human
Application: Enzyme-Linked Immunosorbent Assay (ELISA)
Storage:
Store the RET antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Images

1 / 1
Analysis of HuProt(TM) microarray containing more than 19,000 full-length human proteins using RET antibody (clone RET/2662). These results demonstrate the foremost specificity of the RET/2662 mAb. Z- and S- score: The Z-score represents the strength of a signal that an antibody (in combination with a fluore
❮❯

Analysis of HuProt(TM) microarray containing more than 19,000 full-length human proteins using RET antibody (clone RET/2662). These results demonstrate the foremost specificity of the RET/2662 mAb. Z- and S- score: The Z-score represents the strength of a signal that an antibody (in combination with a fluore

Documents

Further Information

Application Details :
ELISA (order BSA-free format for coating)
Application Note:
Optimal dilution of the antibody should be determined by the researcher.
Description:
The Ret proto-oncogene is structurally related to the growing family of tyrosine kinase transmembrane receptors and is involved in GDNF signaling. RET expression is reported in several regions of the central nervous system; in the developing cranial nerve ganglia and a subset of cells within dorsal root ganglia, in motor neurons in the spinal cord and hindbrain, in neuro-retina and the growing tips of the renal collecting ducts in developing kidney.Alterations in RETgene are associated with diseases including papillary thyroid carcinoma, multiple endocrine neoplasia (type 2A and 2B), familial medullary thyroid carcinoma, and a congenital developmental disorder known as Hirschsprung's disease.
Format :
Purified
Formulation :
0.2 mg/ml with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Immunogen:
A recombinant human partial protein (amino acids 702-848) was used as the immunogen for this RET antibody.
Limitation:
This RET antibody is available for research use only.
Microarray Validated?:
Yes
Purity:
Protein G affinity chromatography
Species Reactivity :
Human
Uniprot #:
P07949